News

Camfil Brings Clean Air Solutions To Dallas' Healthcare Facilities
Camfil provides advanced air filtration solutions for Dallas hospitals, ensuring clean, particle-free air to improve patient ...
Virtune Launches Virtune Coinbase 50 Index ETP On Nasdaq Helsinki
"Listing our Coinbase 50 Index ETP on Nasdaq Helsinki marks a significant milestone in our mission to provide secure and regulated access to digital assets investments in Finland. We are thrilled to ...
Hilbert Group Makes Payment to Liberty Road Capital
STOCKHOLM, SWEDEN / ACCESS Newswire / July 15, 2025 / Hilbert Group AB (STO:HILB-B)(FRA:999) announced on 24 March 2025 the successful closing on an asset purchase deal with Liberty Road Capital.The p ...
AlzeCure Pharma: AlzeCure's Pain Project ACD440 Granted Orphan Drug Status in the US by the FDA
STOCKHOLM, SE / ACCESS Newswire / July 15, 2025 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for diseases ...
PharmiWeb15h
AlzeCure's Pain Project ACD440 Granted Orphan Drug Status in the US by the FDA
STOCKHOLM, SE / ACCESS Newswire / July 15, 2025 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for diseases ...
The Pharma Letter16h
Otsuka bets on Cantargia in deal worth up to $613 million
Japanese drugmaker Otsuka Pharmaceutical (TYO: 4578) has signed a deal to acquire Cantargia’s CAN10 program in a transaction worth up to $613 million. The move hands Otsuka global rights to an ...
Ependion AB: Increased order intake and improved earnings in an uncertain market
Order intake increased by 16 percent to SEK 558 million (483), adjusted for currency effects and acquisitions it increased by 17 percent. Net sales decreased by 5 percent to SEK 561 ...
Baltic Horizon Fund / Northern Horizon Capital: Nasdaq Stockholm has approved Baltic Horizon Fund application for delisting of SDRs
In connection with the planned termination of the Swedish Depositary Receipts ("SDR") of Baltic Horizon Fund, the management board of Northern Horizon Capital AS submitted a delisting application to ...
Egetis Therapeutics AB: Egetis receives FDA Breakthrough Therapy Designation for tiratricol for MCT8 deficiency
Egetis Therapeutics AB (publ) ("Egetis" or the "Company") (NASDAQ Stockholm: EGTX), today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough ...
ShaMaran Reports Incident at Sarsang Facility
ShaMaran Petroleum Corp. ("ShaMaran" or the "Company") (TSXV: SNM) (Nasdaq First North: SNM) has been informed by HKN Energy Ltd. ("HKN"), the operator of the Sarsang Block in the Kurdistan Region of ...
CoinShares Announces Amendment to Financial Calendar
CoinShares International Limited ("CoinShares" or the "Company") (Nasdaq Stockholm Market: CS; US OTCQX: CNSRF), a global investment firm specialising in digital assets, today announces an amendment ...
Cantargia Announces the Acquisition of its CAN10 IL1RAP Immunology Program by Otsuka Pharmaceutical
Cantargia receives an upfront cash payment of USD 33 million. Cantargia is eligible to receive up to USD 580 million in ...